Inventor · disambiguated record
Matthias Wymann
Also filed as: WYMANN MATTHIAS
5 granted patents·6 pending applications·43 citations·filing 2002–2022
77Inventor score
Top patents by PatentIndex Score
11 records- 0188US11186591B2Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidinesTORQUR AG·Filed 2020·Granted Nov 30, 2021·4 cites·14 claims
- 0281US10640516B2Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidinesPIQUR THERAPEUTICS AG·Filed 2015·Granted May 5, 2020·4 cites·21 claims
- 0381US8921361B2Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probesCMILJANOVIC VLADIMIR·Filed 2009·Granted Dec 30, 2014·28 cites·16 claims
- 0478US9556203B2Conformationally restricted P13K and mTOR inhibitorsUNIV BASEL·Filed 2014·Granted Jan 31, 2017·7 cites·16 claims
- 0564US2022153752A1Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidinesTORQUR AG·Filed 2021·Application pending·0 cites
- 0657US2024217960A1Triazine derivative as covalent inhibitors of pi3kUNIV BASEL·Filed 2022·Application pending·0 cites
- 0755US2024241099A1Method for identifying pi3 kinase-alpha inhibitorsUNIV BASEL·Filed 2022·Application pending·0 cites
- 0855US2024208957A1Triazine derivative as reversible and irreversible covalent inhibitors of pi3kUNIV BASEL·Filed 2022·Application pending·0 cites
- 0939US7157239B2Method and kit for identifying and/or quantifying radiolabeled aminoglycoside binding moleculesAPPLIED RESEARCH SYSTEMS·Filed 2002·Granted Jan 2, 2007·0 cites·18 claims
- 1030US2013040912A1Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disordersUNIV BASEL·Filed 2011·Application pending·0 cites
- 1127US2013040934A1Spirocyclic compounds and their use as therapeutic agents and diagnostic probesCMILJANOVIC VLADIMIR·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthias Wymann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →